Kukje Pharma KRX:002720KOSPI
국제약품 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days1
Articles tracked72since Sep 11
In Q2 2026, Kukje Pharma reported revenue of ₩48.3bn, up 7.3% year on year, and operating profit of ₩2.1bn. Kukje Pharma (국제약품) appeared in 0 Korean news articles and 1 DART filing over the past seven days.
Filing signals Control change Share pledge Screener
Kukje Pharma quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩48.3bn | +7.3% | ₩2.1bn margin 4.4% | ₩1.7bn |
| Q1 2026 | ₩44.0bn | +6.0% | ₩2.0bn margin 4.5% | ₩2.1bn |
| Q4 2025 derived | ₩43.3bn | +4.1% | −₩1.5bn margin −3.6% | −₩736m |
| Q3 2025 | ₩45.6bn | +15.1% | ₩1.9bn margin 4.2% | ₩1.9bn |
| Q2 2025 | ₩45.0bn | +19.6% | ₩3.5bn margin 7.8% | ₩2.7bn |
| Q1 2025 | ₩41.5bn | +10.6% | ₩2.3bn margin 5.5% | ₩1.9bn |
| Q4 2024 derived | ₩41.6bn | +18.0% | ₩943m margin 2.3% | ₩697m |
| Q3 2024 | ₩39.7bn | +23.4% | ₩1.7bn margin 4.2% | ₩1.2bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Kukje Pharma top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Kukje Pharma news Korean headlines
-
Jungkook Pharma delivers 750kg of rice to Seongnam Jung-won Senior Welfare Center marking 67th anniversary
2 more on this story · 2 outlets
-
Jungkook Pharma Hyorim Scholarship Foundation delivers 40 million won in scholarships
1 more on this story · 1 outlets
-
Jungkook Pharma Hyorim Scholarship Foundation provides 40 million won in scholarships to 44 students
1 more on this story · 1 outlets
-
Jungkook Pharma marks 67th anniversary: "leap to century-old company through core task execution"
2 more on this story · 2 outlets
-
Jungkook Pharma marks 67th anniversary…pursuing 55.5 billion won eye drops factory construction
1 more on this story · 1 outlets
-
Jungkook Pharma marks 67th anniversary…55.5 billion won eye drops new factory and improved new drug R&D strengthened
1 more on this story · 1 outlets
-
Hyorim E&I, a subsidiary of Jungkook Pharma, selected as excellent environmental enterprise…water treatment technology recognized
1 more on this story · 1 outlets